Organogenesis Holdings Inc.
Organogenesis Holdings Inc., a leading player in the regenerative medicine sector, is headquartered in the United States. Founded in 1985, the company has established itself as a pioneer in advanced wound care and surgical biologics, focusing on innovative solutions that enhance healing and improve patient outcomes. With a strong presence across North America, Organogenesis offers a diverse portfolio of products, including allograft and xenograft tissue products, which are distinguished by their unique biological properties and effectiveness. The company has achieved significant milestones, including FDA approvals for several of its key offerings, solidifying its position in the market. Recognised for its commitment to quality and innovation, Organogenesis continues to lead the way in transforming patient care through its cutting-edge therapies and comprehensive support services.
DitchCarbon Score
How does Organogenesis Holdings Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Organogenesis Holdings Inc.'s score of 23 is lower than 77% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Organogenesis Holdings Inc.'s reported carbon emissions
Organogenesis Holdings Inc., headquartered in the US, currently does not report any specific carbon emissions data, as there are no available figures for emissions in kg CO2e. Additionally, the company has not established any documented reduction targets or commitments to climate initiatives, such as those outlined by the Science Based Targets initiative (SBTi) or other industry standards. As a result, there is no information regarding their scope of emissions (Scope 1, 2, or 3) or any significant achievements in reducing carbon footprints. Without specific data or commitments, it is unclear how Organogenesis Holdings Inc. is addressing climate change or contributing to sustainability efforts within the industry.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Organogenesis Holdings Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
